WaveMan · Form 4
Welch Daniel G insider trades
> Search tickers & screens ⌘K
LIVE

Welch Daniel G insider trades

Welch Daniel G has filed 28 Form 4s with the SEC that we hold, for SGEN (Director), Nuvation Bio Inc. (NUVB) (Director), Structure Therapeutics Inc. (GPCR) (Director) and Ultragenyx Pharmaceutical Inc. (RARE) (Director), among 5 companies in all. Across all of them we count 0 purchases worth $0 and 41 sales worth $19.3M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 8,210 shares of SGEN worth $1.6M, dated 2023-03-13. The first filing on our record is dated 2021-11-02 and the latest 2026-06-18.

SGEN

Director · 10 filings · 41 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-03-13S, sale reported on Form 45,758$1.2M2023-03-16
2023-03-13S, sale reported on Form 48,210$1.6M2023-03-16
2023-03-13S, sale reported on Form 4808$162.8K2023-03-16
2023-03-13S, sale reported on Form 4173$35.0K2023-03-16
2023-03-13S, sale reported on Form 444$8.9K2023-03-16
2023-03-13S, sale reported on Form 4214$43.1K2023-03-16
2023-03-13S, sale reported on Form 42,098$420.0K2023-03-16
2023-03-13S, sale reported on Form 47,629$1.5M2023-03-16
2023-03-13S, sale reported on Form 41,348$271.7K2023-03-16
2023-03-13S, sale reported on Form 4283$57.3K2023-03-16
2023-03-14S, sale reported on Form 4470$94.0K2023-03-16
2023-03-14S, sale reported on Form 4288$57.6K2023-03-16
2023-03-14S, sale reported on Form 474$14.8K2023-03-16
2023-03-15S, sale reported on Form 41,246$249.3K2023-03-17
2023-03-15S, sale reported on Form 4320$64.0K2023-03-17
2023-03-15S, sale reported on Form 42,037$407.5K2023-03-17
2023-04-03S, sale reported on Form 41,082$219.1K2023-04-05
2023-04-03S, sale reported on Form 43,124$626.2K2023-04-05
2023-04-03S, sale reported on Form 43,317$668.4K2023-04-05
2023-04-03S, sale reported on Form 44,284$867.7K2023-04-05
2023-04-03S, sale reported on Form 4851$171.5K2023-04-05
2023-04-03S, sale reported on Form 4817$163.8K2023-04-05
2023-04-03S, sale reported on Form 4112$22.7K2023-04-05
2023-04-03S, sale reported on Form 47,158$1.4M2023-04-05
2023-04-03S, sale reported on Form 45$1.0K2023-04-05
2023-04-03S, sale reported on Form 43,575$720.7K2023-04-05
2023-04-03S, sale reported on Form 45,680$1.1M2023-04-05
2023-04-03S, sale reported on Form 4995$199.1K2023-04-05
2023-05-01S, sale reported on Form 44,890$978.3K2023-05-03
2023-05-01S, sale reported on Form 4295$59.0K2023-05-03
2023-05-01S, sale reported on Form 41,990$398.2K2023-05-03
2023-05-01S, sale reported on Form 45,150$1.0M2023-05-03
2023-05-02S, sale reported on Form 43,462$692.7K2023-05-03
2023-05-02S, sale reported on Form 43,171$634.4K2023-05-03
2023-05-02S, sale reported on Form 41,888$377.7K2023-05-03
2023-05-02S, sale reported on Form 4351$70.2K2023-05-03
2023-05-02S, sale reported on Form 45,835$1.2M2023-05-03
2023-05-15S, sale reported on Form 41,864$372.8K2023-05-16
2023-08-28S, sale reported on Form 41,610$336.6K2023-08-29
2023-08-28S, sale reported on Form 41,812$378.7K2023-08-29
2023-08-28S, sale reported on Form 41,503$314.4K2023-08-29

Nuvation Bio Inc. (NUVB)

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Structure Therapeutics Inc. (GPCR)

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Ultragenyx Pharmaceutical Inc. (RARE)

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Prothena Corp Public LTD Co (PRTA)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1206199) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms